Paul DeLucca

5.1k total citations · 1 hit paper
24 papers, 3.5k citations indexed

About

Paul DeLucca is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Paul DeLucca has authored 24 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 9 papers in Surgery and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Paul DeLucca's work include Heart Failure Treatment and Management (6 papers), Acute Myocardial Infarction Research (5 papers) and Cardiac Imaging and Diagnostics (4 papers). Paul DeLucca is often cited by papers focused on Heart Failure Treatment and Management (6 papers), Acute Myocardial Infarction Research (5 papers) and Cardiac Imaging and Diagnostics (4 papers). Paul DeLucca collaborates with scholars based in United States, Italy and Poland. Paul DeLucca's co-authors include Laura A. Demopoulos, Peter M. DiBattiste, Franz‐Josef Neumann, Eugene Braunwald, William S. Weintraub, Christopher P. Cannon, Debbie Robertson, Nasser Lakkis, Ralph Vicari and Martin J. Frey and has published in prestigious journals such as New England Journal of Medicine, Circulation and Annals of Internal Medicine.

In The Last Decade

Paul DeLucca

23 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparison of Early Invasive and Conservative Strategies in Patients with Unstable Coronary Syndromes Treated with the Glycoprotein IIb/IIIa Inhibitor Tirofiban

2001 1.4k citations Christopher P. Cannon, William S. Weintraub et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Paul DeLucca

Since Specialization

Citations

This map shows the geographic impact of Paul DeLucca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul DeLucca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul DeLucca more than expected).

Fields of papers citing papers by Paul DeLucca

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul DeLucca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul DeLucca. The network helps show where Paul DeLucca may publish in the future.

Co-authorship network of co-authors of Paul DeLucca

This figure shows the co-authorship network connecting the top 25 collaborators of Paul DeLucca. A scholar is included among the top collaborators of Paul DeLucca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul DeLucca. Paul DeLucca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effects of the Adenosine A1 Receptor Antagonist Rolofylline on Renal Function in Patients With Acute Heart Failure and Renal Dysfunction 2011 ·Journal of the American College of Cardiology ·Adriaan A. Voors, Howard C. Dittrich, Barry M. Massie, Paul DeLucca, George A. Mansoor, Marco Metra, Gad Cotter, Beth Davison Weatherley, Piotr Ponikowski, John R. Teerlink, John G.F. Cleland, Christopher M. O’Connor, Michael M. Givertz	101
2	Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT Study 2011 ·European Heart Journal ·Marco Metra, Cathal O’Connor, Beth A. Davison, John G.F. Cleland, Piotr Ponikowski, John R. Teerlink, Adriaan A. Voors, Michael M. Givertz, George A. Mansoor, Daniel M. Bloomfield, Gang Jia, Paul DeLucca, Barry M. Massie, H. Dittrich, Gad Cotter	74
3	EFFECTS OF THE ADENOSINE A1-ANTAGONIST ROLOFYLLINE ON RENAL FUNCTION IN ACUTE HEART FAILURE PATIENTS: RESULTS FROM THE PROTECT STUDY 2010 ·Journal of the American College of Cardiology ·Adriaan A. Voors, Howard C. Dittrich, Barry M. Massie, Paul DeLucca, George A. Mansoor, Michael M. Givertz	1
4	Rolofylline, an Adenosine A₁−Receptor Antagonist, in Acute Heart Failure 2010 ·New England Journal of Medicine ·Barry M. Massie, Christopher M. O’Connor, Marco Metra, Piotr Ponikowski, John R. Teerlink, Gad Cotter, Beth Davison Weatherley, John G.F. Cleland, Michael M. Givertz, Adriaan A. Voors, Paul DeLucca, George A. Mansoor, Christina M. Salerno, Daniel M. Bloomfield, Howard C. Dittrich	379
5	Design and Rationale of the PROTECT Study: A Placebo-controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function 2009 ·Journal of Cardiac Failure ·Beth Davison Weatherley, Gad Cotter, Howard C. Dittrich, Paul DeLucca, George A. Mansoor, Daniel M. Bloomfield, Piotr Ponikowski, Christopher M. O’Connor, Marco Metra, Barry M. Massie	66
6	Treatment with alendronate plus calcium, alendronate alone, or calcium alone for postmenopausal low bone mineral density 2007 ·Current Medical Research and Opinion ·Sydney Lou Bonnick, Susan B. Broy, Fran E. Kaiser, Carol Teutsch, Elizabeth Rosenberg, Paul DeLucca, Mary E. Melton	53
7	Efficacy of simvastatin therapy in attainment of LDL-C and TG goal levels in patients with type 2 diabetic dyslipidemia 2007 ·Journal of clinical lipidology ·Adrian S. Dobs, Michael Miller, Paul DeLucca, Karen E. Ramsey, Andrew M. Tershakovec, (unknown)	2
8	Efficacy and Safety of Ezetimibe and Ezetimibe Plus Statin Therapy in Patients Aged Under 65, 65–74 and 75 Years and Older 2007 ·Aging Health ·Jennifer G. Robinson, Michael H. Davidson, Arvind Shah, Jianxin Lin, David Neff, Paul DeLucca, Joanne E. Tomassini, Enrico P. Veltri, Andrew M. Tershakovec	23
9	Dorzolamide/Timolol Fixed Combination Versus Concomitant Administration of Brimonidine and Timolol in Patients with Elevated Intraocular Pressure 2004 ·Journal of Glaucoma ·(unknown), Paul DeLucca, (unknown), (unknown), Carolyn M. Hustad, Franck Skobieranda	27
10	The Effect of Routine, Early Invasive Management on Outcome for Elderly Patients with Non–ST-Segment Elevation Acute Coronary Syndromes 2004 ·Annals of Internal Medicine ·Richard G. Bach, Christopher P. Cannon, William S. Weintraub, Peter M. DiBattiste, Laura A. Demopoulos, H. Vernon Anderson, Paul DeLucca, Elizabeth M. Mahoney, Sabina A. Murphy, Eugene Braunwald	268
11	Effect on high-density lipoprotein cholesterol of maximum dose simvastatin and atorvastatin in patients with hypercholesterolemia: Results of the Comparative HDL Efficacy and Safety Study (CHESS) 2003 ·American Heart Journal ·Christie M. Ballantyne, Michael A. Blazing, Donald B. Hunninghake, Michael H. Davidson, Žhong Yuan, Paul DeLucca, Karen E. Ramsey, Carolyn M. Hustad, Joanne Palmisano	59
12	Comparison of Early Invasive and Conservative Strategies in Patients with Unstable Coronary Syndromes Treated with the Glycoprotein IIb/IIIa Inhibitor Tirofiban breakdown → 2001 ·New England Journal of Medicine ·Christopher P. Cannon, William S. Weintraub, Laura A. Demopoulos, Ralph Vicari, Martin J. Frey, Nasser Lakkis, Franz‐Josef Neumann, Debbie Robertson, Paul DeLucca, Peter M. DiBattiste, C. Michael Gibson, Eugene Braunwald	1390
13	Losartan versus valsartan in the treatment of patients with mild to moderate essential hypertension: data from a multicenter, randomized, double-blind, 12-week trial 2001 ·Clinical Therapeutics ·W.J. Elliott, David A. Calhoun, Paul DeLucca, (unknown), (unknown), Robert K. Zeldin	40
14	Comparison of Two Platelet Glycoprotein IIb/IIIa Inhibitors, Tirofiban and Abciximab, for the Prevention of Ischemic Events with Percutaneous Coronary Revascularization 2001 ·New England Journal of Medicine ·Eric J. Topol, David J. Moliterno, Howard C. Herrmann, Eric R. Powers, Cindy L. Grines, David J. Cohen, Eric A. Cohen, Michel E. Bertrand, Franz‐Josef Neumann, Gregg W. Stone, Peter M. DiBattiste, Steven J. Yakubov, Paul DeLucca, Laura A. Demopoulos	469
15	Effect of investigator bias on the significance level of the Wilcoxon rank-sum test 2000 ·Biostatistics ·Paul DeLucca, Damaraju Raghavarao	3
16	Oral Montelukast Compared with Inhaled Salmeterol To Prevent Exercise-Induced Bronchoconstriction 2000 ·Annals of Internal Medicine ·Jonathan M. Edelman, Jennifer Turpin, Edwin A. Bronsky, Jay Grossman, James P. Kemp, (unknown), Paul DeLucca, Glenn J. Gormley, David S. Pearlman, (unknown)	153
17	Effect of Indomethacin on Blood Pressure Lowering by Captopril and Losartan in Hypertensive Patients 2000 ·Hypertension ·Paul R. Conlin, Thomas J. Moore, Stephen L. Swartz, Eliav Barr, (unknown), (unknown), Paul DeLucca, Laura A. Demopoulos	66
18	Results of the Treat Angina With Aggrastat and Determine the Cost of Therapy With an Invasive or Conservative Strategy (TACTICS-TIMI 18) Trial: A Comparison of Invasive Versus Conservative Strategy in Patients With Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction 2000 ·Circulation ·Christopher P. Cannon, William S. Weintraub, Laura A. Demopoulos, Debbie Robertson, Paul DeLucca, Carolyn H. McCabe, Eugene Braunwald	8
19	EFFECT OF INVESTIGATOR BIAS ON THE POWER AND LEVEL OF THE TWO-SAMPLE Z-TEST 1999 ·Journal of Biopharmaceutical Statistics ·Paul DeLucca, Damaraju Raghavarao, (unknown)	3
20	Precision and Discriminatory Ability of Calcaneal Bone Assessment Technologies 1997 ·Journal of Bone and Mineral Research ·Susan L. Greenspan, Mary Bouxsein, Mary E. Melton, (unknown), James H. Clair, Paul DeLucca, Michael Stek, Kenneth G. Faulkner, Eric Orwoll	162

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact